Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

J&J/Guidant Will Share RX Stent Delivery With Abbott If Guidant Deal Closes

This article was originally published in The Gray Sheet

  • News

Executive Summary

Abbott could be a strong player in the drug-eluting stent market by 2007 if the J&J/Guidant merger is completed as required by FTC

You may also be interested in...



Zoll’s AutoPulse CPR-Assist Device Helps Resuscitate Stock, Up 24% In Q2

Zoll Medical's accelerating revenue growth, driven in part by strong sales of its AutoPulse CPR-assist device, helped fuel a 24.4% jump in the firm's stock price in the second quarter

Zoll’s AutoPulse CPR-Assist Device Helps Resuscitate Stock, Up 24% In Q2

Zoll Medical's accelerating revenue growth, driven in part by strong sales of its AutoPulse CPR-assist device, helped fuel a 24.4% jump in the firm's stock price in the second quarter

Guidant Accepts Yet Another J&J Bid As Takeover War Escalates

Guidant accepted an increased takeover bid by Johnson & Johnson late Jan. 13, leaving Boston Scientific to once again weigh whether to continue its bidding war with J&J

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight
Tags:
Latest Headlines

More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight

Mini-Slings Are Comparable To Traditional Ones To Treat Incontinence, FDA Says

See All
UsernamePublicRestriction

Register

MT022867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By